ARTICLE
30 September 2014

FDA Issues Emergency Use Authorization For Ebola IVD

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
FDA announced it had issued an Emergency Use Authorization for an in vitro diagnostic device to detect of the Ebola Zaire virus.
United States Food, Drugs, Healthcare, Life Sciences

In the September 17, 2014, Federal Register, FDA announced it had issued an Emergency Use Authorization for an in vitro diagnostic device to detect of the Ebola Zaire virus (detected in the West Africa outbreak in 2014) at the request of the Department of Defense.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More